Finalization and pretesting of a Quality of Life Questionnaire for cancer survivors
Phase 3
- Conditions
- Health Condition 1: C819- Hodgkin lymphoma, unspecifiedHealth Condition 2: C500- Malignant neoplasm of nipple and areolaHealth Condition 3: C649- Malignant neoplasm of unspecifiedkidney, except renal pelvis
- Registration Number
- CTRI/2021/04/032852
- Lead Sponsor
- The Netherlands Cancer Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
INCLUSION CRITERIA:
1. Patients of either gender and aged >= 18 years
2. Mentally fit to complete a questionnaire
3. Able to understand the language of the questionnaire
4. Patient is willing to give written informed consent
5. Confirmed cancer diagnosis with one of 11 tumor types
6. Patient has only one cancer diagnosis
7. At least 12 months post-primary treatment with curative intent (exception glioma and
maintenance therapies eg tamoxifen)
8. No evidence of active disease (exception glioma grade I, II, and III)
Exclusion Criteria
EXCLUSION CRITERIA:
1. Patients not willing to provide written signed informed consent for study participation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Development of a health-related quality of life questionnaire (HRQOL) in cancer survivors.Timepoint: Post 1 year after the end of curative treatment.
- Secondary Outcome Measures
Name Time Method 1) To determine the minimum time when the survivorship long-term health-related quality of life (HRQOL) questionnaire should be used in cancer survivors after they have completed the curative treatment.Timepoint: 1-10 years post the end of curative treatment